Indeed, in co-culture with macrophages and murlentamab-opsonized tumor cells, we reported an increased proportion of activated CD8+ and Th1 CD4+ T cells as well as a reduced proportion of CD25+ CD4+ Tregs. This evidence concerns the gene CD4 and neoplasm.